platelet-type bleeding disorder 11

ICD-10 Codes

Related ICD-10:

Description

Platelet-Type Bleeding Disorder 11 (PTBD-11)

Platelet-type bleeding disorder 11, also known as PTBD-11, is a rare autosomal recessive condition characterized by defective platelet activation and aggregation in response to collagen. This leads to mild to moderate bleeding symptoms.

  • Causes: PTBD-11 is caused by mutations in the GP6 gene, which plays a crucial role in platelet activation and aggregation.
  • Symptoms: Patients with PTBD-11 may experience mucocutaneous bleeding, such as easy bruising or bleeding from minor cuts. Gastrointestinal tract bleeding is also a common manifestation of this condition.

Key Points

  • PTBD-11 is an autosomal recessive condition, meaning that individuals must inherit two copies of the mutated gene (one from each parent) to develop the disorder.
  • The condition affects platelet function, leading to impaired blood clotting and increased bleeding tendency.
  • Symptoms can range from mild to moderate and may include mucocutaneous bleeding, gastrointestinal tract bleeding, and other bleeding manifestations.

References

  1. [4] describes PTBD-11 as an autosomal recessive condition characterized by defective platelet activation and aggregation in response to collagen.
  2. [5] states that PTBD-11 is a bleeding disorder associated with a mutation in the GP6 gene.
  3. [9] mentions that gastrointestinal tract bleeding is the most frequent manifestation of PTBD-11.

Note: The information provided above is based on the search results and context provided, and is intended to be informative and relevant to the user's query.

Additional Characteristics

  • Rare autosomal recessive condition
  • Platelet-type bleeding disorder 11 (PTBD-11)
  • Defective platelet activation and aggregation in response to collagen
  • Mild to moderate bleeding symptoms
  • Autosomal recessive condition, individuals must inherit two copies of the mutated gene
  • Impaired blood clotting and increased bleeding tendency
  • Mucocutaneous bleeding, gastrointestinal tract bleeding, and other bleeding manifestations

Signs and Symptoms

Common Signs and Symptoms of Platelet-Type Bleeding Disorder

People with platelet disorders, including platelet-type bleeding disorders, may experience a range of symptoms due to the body's inability to form proper blood clots. Some common signs and symptoms include:

  • Bleeding: Easy bruising, bleeding from minor cuts or injuries, and prolonged bleeding after surgery or trauma.
  • Bruising: Frequent bruising from minor trauma, such as falling or bumping into objects.
  • Prolonged bleeding: Bleeding that lasts longer than usual after an injury or surgery.
  • Petechiae: Tiny red dots (petechiae) on the skin due to small blood vessels breaking.

These symptoms can vary in severity and may be more pronounced in some individuals than others. In some cases, people with platelet disorders may not experience any noticeable symptoms at all.

References:

  • [3] Symptoms of Platelet Disorders. A low platelet count and platelet dysfunction often cause bleeding in the skin as the first sign.
  • [6] Generally symptoms of a platelet disorder are similar, with bruising from minor trauma, bleeding from the mouth, nose or digestive system and excessive bleeding ...
  • [7] People with platelet function disorders tend to bleed or bruise more easily. They may have a normal number of platelets or a low platelet count. Their platelet ...

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Platelet-Type Bleeding Disorder 11

Platelet-type bleeding disorder 11 (PTBD11) is a rare autosomal recessive condition characterized by defective platelet activation and aggregation in response to collagen. Diagnosing PTBD11 can be challenging, but various laboratory tests can help confirm the diagnosis.

Initial Laboratory Testing

The initial workup for detecting inherited platelet disorders should begin with a careful review of the complete blood cell count (CBC) and peripheral blood smear results [4]. These tests are useful in identifying abnormalities in platelet count, size, shape, and morphology. A CBC with platelet count and a peripheral smear can help identify conditions that may mimic PTBD11.

Platelet Tests

Platelet tests check for conditions that cause too much bleeding or blood clotting. They include:

  • Platelet count test: This measures the number of platelets in the blood.
  • Platelet function analyzer 100 (PFA-100): This test evaluates platelet function by measuring the time it takes for platelets to pass through a small aperture under high shear stress [14].
  • Light transmission platelet aggregometry: This test assesses platelet aggregation in response to various agonists, such as collagen and ADP.
  • Electrical impedance whole blood aggregometry: This test evaluates platelet function by measuring the change in electrical impedance as platelets aggregate.

Genetic Testing

Genetic testing can confirm the diagnosis of PTBD11. The Platelet Disorders Gene Sequencing Panel utilizes Exome Sequencing (ES) technology to identify inherited forms of platelet dysfunction [5]. This panel includes genes associated with various platelet disorders, including PTBD11.

Transmission Electron Microscopy (TEM)

Platelet transmission electron microscopy (TEM) can help diagnose PTBD11 by visualizing the ultrastructure of platelets. TEM can reveal abnormalities in platelet morphology and structure that are characteristic of PTBD11 [14].

These diagnostic tests can help confirm the diagnosis of platelet-type bleeding disorder 11. However, a comprehensive evaluation by a hematologist or a geneticist is essential to determine the best course of action for each patient.

References:

[4] Perez Botero J, Di Paola J. Diagnostic approach to the patient with a suspected inherited platelet disorder: who and how to test. [5] The Platelet Disorders Gene Sequencing Panel. [14] Clinical workup for detecting inherited platelet disorders should begin with a careful review of the complete blood cell count and peripheral blood smear results as well as other platelet tests.

Treatment

Treatment Options for Platelet-Type Bleeding Disorder

Platelet-type bleeding disorders, also known as Glanzmann thrombasthenia (GT), are rare genetic conditions characterized by qualitative or quantitative abnormalities in the platelet fibrinogen receptor. While there is no cure for GT, various treatment options can help manage symptoms and prevent bleeding episodes.

  • Desmopressin: This medication can increase levels of platelets in the blood by releasing them from storage. It is often used as a first-line treatment for mild to moderate cases of GT.
  • Platelet transfusions: In more severe cases, platelet transfusions may be necessary to replace dysfunctional platelets and prevent bleeding.
  • Von Willebrand factor-rich concentrates: These concentrates can help restore normal platelet function by providing the necessary von Willebrand factor (VWF) protein.

Other Treatment Options

In addition to these specific treatments for GT, other medications may also be used to manage symptoms and prevent bleeding episodes. For example:

  • Recombinant activated factor VII (NovoSeven): This medication can help promote blood clotting in patients with platelet-related bleeding disorders.
  • Antifibrinolytic agents: These medications can help reduce the breakdown of clots and prevent excessive bleeding.

Important Considerations

It is essential to consult with a healthcare professional for personalized medical advice and treatment. They will be able to assess individual needs and develop an appropriate treatment plan based on the severity of the condition, age, and overall health status.

References:

  • [1] Specific Disorders of Platelet Function Defects of Platelet Receptors Glanzmann Thrombasthenia.
  • [9] by M Othman ยท 2020 ยท Cited by 33 โ€” Platelet transfusions and von Willebrand factor-rich concentrates (if VWF is low) are the most effective treatments.
  • [10] Use of autologous platelet-rich clots has also been reported to be effective in skin biopsy and dental extraction in patients with type 2 VWD, platelet-type VWD, and GT.

Recommended Medications

๐Ÿ’Š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Platelet-Type Bleeding Disorder

A platelet-type bleeding disorder can be caused by various conditions, and differential diagnosis is essential to identify the underlying cause. Here are some possible causes:

  • Idiopathic Thrombocytopenic Purpura (ITP): A condition characterized by low platelet count, leading to bleeding and bruising.
  • Thrombotic Thrombocytopenic Purpura (TTP): A rare blood disorder that affects the production of platelets, leading to thrombocytopenia and microangiopathic hemolytic anemia.
  • Bleeding Disorders: Conditions such as von Willebrand disease (vWD), Bernard-Soulier syndrome (BSS), and MYH9-related disorders can cause platelet-type bleeding disorder.

Key Findings or Clues to Diagnosis

  • Bleeding, bruising, petechia, or purpura
  • Consider ITP, TTP, vWD, BSS, or MYH9-related disorders

According to [11], the differential diagnosis of platelet-type bleeding disorder involves considering various conditions that can cause similar symptoms. A thorough evaluation and laboratory tests are necessary to determine the underlying cause.

References

[11] Disorder Findings or clues to diagnosis; Bleeding: Platelet disorders (quantitative) Bleeding, bruising, petechia, or purpura Consider idiopathic thrombocytopenic purpura, thrombotic thromocytopenic purpura, von Willebrand disease, Bernard-Soulier syndrome, or MYH9-related disorders.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5392
owl#annotatedSource
t375356
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
ORDO:98885
oboInOwl#id
DOID:0111057
core#notation
DOID:0111057
oboInOwl#hasExactSynonym
GP VI deficiency
rdf-schema#label
platelet-type bleeding disorder 11
IAO_0000115
A blood platelet disease characterized by autosomal recessive inheritance of mild to moderate bleeding and defective platelet activation and aggregation in response to collagen that has_material_basis_in compound heterozygous mutation in the GP6 gene on chromosome 19q13.
rdf-schema#subClassOf
t375131
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
RO_0002452
http://purl.obolibrary.org/obo/SYMP_0000007
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
relatedICD
http://example.org/icd10/D69.8
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.